12:00 AM
 | 
Jun 25, 2012
 |  BC Week In Review  |  Company News  |  Deals

MicroDose Therapeutx, Moerae Matrix deal

The companies partnered to use MicroDose's inhaler technology to develop a dry powder formulation of Moerae's MMI-0100. The MAP kinase-activated protein kinase 2...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >